BeiGene

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. How AI can optimise your pharmaceutical manufacturing processes and raise throughput Artificial intelligence (AI) allows pharmaceutical manufacturers to perform predictive maintenance, which can reduce downtime and enhance process efficiency
  3. Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways
  4. Bormioli Pharma to digitise package leaflets using augmented reality The project is part of the Bormioli Pharma Invents innovation programme, which aims to provide concrete answers to some of the most important challenges in the pharmaceutical...
  5. Syncona launches early-stage drug development company, Slingshot Therapeutics The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around...

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Ingredients

Therapeutic: tislelizumab for oncology

With three main subtypes (adenocarcinoma, squamous cell carcinoma and large cell), non-small cell lung cancer is the predominant form of lung cancer
Manufacturing

Boehringer is first to take advantage of new Chinese regulations

Tislelizumab is the first biopharmaceutical manufactured by a multinational CDMO in China and the first commissioned under the new MAH model in the country
Manufacturing

Immuno-oncology specialist chooses Catalent for commercial supply

Catalent has agreed to manufacture BRUKINSA (zanubrutinib), an inhibitor that has recently received accelerated approval from the US FDA
Manufacturing

Boosting manufacturing capacity BeiGene selects GE Healthcare

The commercial-stage biotechnology company will now have late-stage clinical and commercial production capacity for cancer monoclonal antibodies using a prefabricated biopharma facility built by the global healthcare provider
Manufacturing

Boehringer Ingelheim wins China's first biopharmaceutical CMO pilot project

Boehringer Ingelheim China’s first client under the pilot is Beijing-based biotech company BeiGene
Manufacturing

BeiGene to install GE’s FlexFactory for pilot cGMP production facility in China

Facility will manufacture biologics for clinical trials
Design & Build

BeiGene signs agreement with BioBAY

Company announces first cGMP manufacturing facility for commercial use in Suzhou, China
Subscribe now